1480
C.-K. Sha et al. / Tetrahedron 59 (2003) 1477–1481
1500, 1440, 1390, 1350, 1250, 1170, 1120, 1060,
1
2.98 (ABq, 2H, J¼23.5, 6.8 Hz), 5.69 (br s, 1H), 5.79 (br s,
1H), 7.29–7.50 (m, 7H), 7.80–7.84 (m, 2H); MS (EI): m/z
446 (Mþ, 12), 273 (74), 217 (100), 173 (74); 13C NMR
(CDCl3, 125 MHz): d 28.0, 29.7, 50.4, 63.0, 64.5, 82.1,
122.2, 123.8, 125.0, 125.3, 126.5, 128.9, 129.3, 131.3,
131.6, 145.5, 155.0, 174.1, 174.4; HRMS (EI): calcd for
C25H22N2O4S 446.1300, found 446.1301.
1020 cm21; H NMR (CDCl3, 400 MHz): d 5.22 (s, 2H),
6.78 (d, 1H, J¼2.0 Hz), 7.15–7.32 (m, 8H), 7.62 (d, 1H,
J¼8.0 Hz), 7.69–7.71 (m, 1H); 13C NMR (CDCl3,
100.6 MHz): d 54.4, 110.7, 111.6, 121.0, 121.8, 123.3,
124.0, 124.2, 127.0, 127.8, 128.3, 128.7, 131.4, 137.5,
143.4; MS (EI): m/z 263 (Mþ, 100); HRMS (EI): calcd for
C17H13NS 263.0769, found 263.0769.
1.1.14. Diels–Alder reaction of compound 12 with
N-phenylmaleimide. The reaction was carried out at
room temperature for 24 h using compound 12 (62 mg,
0.24 mmol) and N-phenylmaleimide (122 mg, 0.71 mmol)
in dry benzene. Concentration and silica gel column
chromatography (EtOAc/hexane, 1:8) gave exo cycloadduct
17 (6.8 mg, 7%) as a white solid; mp 143.9–144.58C; IR
(CHCl3): 1770, 1700, 1590, 1515, 1390, 1290, 1190,
1.1.10. 2-Phenyl-2H-benzo[4,5]thieno[2,3-c]pyrrole (13).
The procedure was similar to that of compound 9. The
reaction mixture, containing bromo compound 5 (369 mg,
0.93 mmol), aniline (259 mg, 2.8 mmol) and 95% ethanol
(6 mL), was stirred at room temperature for 8 h. Concen-
tration and silica gel column chromatography (EtOAc/
hexane, 1:5) gave compound 13 (207 mg, 89%) as white
crystals; mp 118.9–119.58C; UV (CH2Cl2) lmax (nm)
(log 1): 284.1 (4.6), 257.7 (4.5), 224.8 (4.4); IR (CHCl3):
1600, 1560, 1500, 1440, 1390, 1340, 1270, 1040 cm21; 1H
NMR (CDCl3, 400 MHz): d 7.19 (d, 1H, J¼2.1 Hz), 7.27–
7.34 (m, 3H), 7.47–7.50 (m, 4H), 7.57 (d, 1H, J¼1.6 Hz),
7.68–7.70 (m, 1H), 7.81–7.83 (m, 1H); 13C NMR (CDCl3,
125 MHz): d 109.1, 109.7, 121.2, 121.4, 123.4, 124.0,
124.3, 125.0, 126.3, 129.7, 131.1, 141.0, 143.7; MS (EI):
m/z 249 (Mþ, 100); HRMS (EI): calcd for C16H11NS
249.0612, found 249.0592.
1
1160 cm21; H NMR (CDCl3, 400 MHz): d 2.97 (ABq,
2H, J¼18.5, 6.8 Hz), 3.64 (s, 2H), 4.81 (s, 1H), 4.90 (s, 1H),
7.15–7.54 (m, 12H), 7.75 (d, 1H, J¼8.0 Hz), 7.84 (d, 1H,
J¼8.0 Hz); 13C NMR (CDCl3, 125 MHz): d 50.0, 50.5,
51.3, 65.9, 67.8, 122.0, 124.0, 124.5, 125.1, 126.6, 127.4,
128.2, 128.6, 128.8, 129.3, 132.1, 132.7, 138.1, 144.6,
146.3, 146.8, 175.4, 175.7; MS (EI): m/z 263 (Mþ2173,
100), 173 (Mþ2263, 60); HRMS (FAB): calcd for (MþH)
C27H21N2O2S 437.1324, found 437.1319.
1.1.15. Diels–Alder reaction of compound 7 with
dimethyl acetylenedicarboxylate. To a solution of com-
pound 7 (11 mg, 0.04 mmol) in dry ether (5 mL), dimethyl
acetylenedicarboxylate (6.4 mg, 0.045 mmol) was added.
The reaction mixture was heated at reflux for 12 h.
Concentration and silica gel column chromatography
(EtOAc/hexane, 1:1) gave compound 18 (14 mg, 80%) as
a yellow liquid; IR (CHCl3): 2985, 1725, 1630, 1440, 1370,
1.1.11. 3,4-Dihydrobenzo[4,5]thieno[2,3-d]pyridazine
(14). To a solution of bromo compound 5 (416 mg,
1.05 mmol) in 95% ethanol (5 mL), hydrazine (101 mg,
3.15 mmol) was added and stirred at room temperature for
30 min. Removal of solvent followed by silica gel column
chromatography (EtOAc/hexane, 2:1) gave compound 14
(159 mg, 81%) as white crystals; IR (CHCl3): 3400, 3000,
1
2800, 1550, 1470, 1430, 1315, 1070 cm21
;
1H NMR
1330, 1260, 1160 cm21; H NMR (CDCl3, 400 MHz): d
(CDCl3, 400 MHz): d 4.47 (s, 2H), 5.90 (br s, 1H), 7.24–
7.34 (m, 2H), 7.63 (s, 1H), 7.69–7.75 (m, 2H); MS (EI): m/z
188 (Mþ, 67), 187 (100).
1.34 (s, 9H), 3.72 (s, 3H), 3.74 (s, 3H), 5.91 (br s, 1H), 6.03
(br s, 1H), 7.20–7.24 (m, 1H), 7.30–7.34 (m, 1H), 7.69–
7.73 (m, 2H); 13C NMR (CDCl3, 125 MHz): d 28.0, 52.5,
52.5, 67.9, 68.3, 69.2, 69.5, 82.0, 121.3, 121.6, 123.6, 124.3,
125.0, 132.9, 144.3, 152.5, 153.1, 154.0, 162.8; MS (EI):
m/z 415 (Mþ, 55), 217 (100); HRMS (EI): calcd for
C21H21NO6S 415.1090, found 415.1096.
1.1.12. Benzo[4,5]thieno[2,3-d]pyridazine (15). Substrate
14 (159 mg, 0.85 mmol) was kept under open atmosphere
for 4 days. Crude product was purified by silica gel column
chromatography (EtOAc/hexane, 2:1) to give compound 15
(80 mg, 50%) as a brown solid; mp 125.8–126.58C (lit.;8
mp 1268C); UV (CH2Cl2) lmax (nm) (log 1): 325.3 (3.85),
251.7 (4.5), 233.0 (4.8); IR (CHCl3): 1600, 1550, 1520,
1.1.16. Diels–Alder reaction of compound 12 with
dimethyl acetylenedicarboxylate. The reaction was car-
ried out at room temperature for 12 h using compound 12
(80 mg, 0.30 mmol) and dimethyl acetylenedicarboxylate
(56 mg, 0.39 mmol) in dry benzene. Concentration and
silica gel column chromatography (EtOAc/hexane, 3:1)
gave compound 19 (66 mg, 43%) as a yellow liquid; IR
(CHCl3): 3000, 2950, 2840, 1725, 1630, 1440, 1295, 1200,
1100 cm21; 1H NMR (CDCl3, 400 MHz): d 3.62–3.68 (m,
8H), 5.01 (br s, 1H), 5.13 (br s, 1H), 7.15–7.28 (m, 7H),
7.60 (d, 1H, J¼8.0 Hz), 7.68 (d, 1H, J¼8.0 Hz); 13C NMR
(CDCl3, 125 MHz): d 52.3, 53.4, 54.0, 71.1, 72.5, 121.3,
123.8, 124.9, 127.5, 128.6, 129.3, 137.1, 153.3; MS (EI):
m/z 405 (Mþ, 46), 263 (Mþ2142, 100); HRMS (EI): calcd
for C23H19NO4S 405.1035, found 405.1032.
1430, 1320, 1230, 1100, 1030 cm21 1H NMR (CDCl3,
;
400 MHz): d 7.50–7.60 (m, 2H), 7.89–7.92 (m, 1H), 8.22–
8.25 (m, 1H), 9.61 (d, 1H, J¼1.2 Hz), 9.72 (d, 1H,
J¼2.0 Hz); 13C NMR (CDCl3, 125 MHz): d 123.0, 123.4,
126.1, 130.0, 131.9, 132.6, 139.8, 140.5, 144.3, 146.8; MS
(EI): m/z 186 (Mþ, 100), 158 (29), 114 (32); HRMS (EI):
calcd for C10H6N2S 186.0252, found 186.0234.
1.1.13. Diels–Alder reaction of compound 7 with
N-phenylmaleimide. To a solution of compound 7
(16 mg, 0.06 mmol) in dry benzene (5 mL), N-phenyl-
maleimide (31 mg, 0.18 mmol) was added. The reaction
mixture was then heated at reflux for 3 h. The solution was
then filtered and concentrated to give exo cycloadduct 16
(19 mg, 72%) as a white solid; mp 222.2–223.58C; IR
(KBr): 2980, 1780, 1710, 1685, 1490, 1415, 1280, 1200,
1.1.17. Dimethyl dibenzo[b,d]thiophene-2,3-dicarboxyl-
ate (21). To a solution of substrate 19 (10 mg, 0.026 mmol)
in dry CH2Cl2 (1 mL), a solution of m-CPBA (4.5 mg,
0.026 mmol) in dry CH2Cl2 (1 mL) was slowly added. The
1
1100 cm21; H NMR (CDCl3, 400 MHz): d 1.32 (s, 9H),